Tilray | TRLY - Ordinary Share Capital


Tilray reported $116.52M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Acasti Pharma USD 1000 261.04M Dec/2024
Akebia Therapeutics USD 265.42M 199K Dec/2025
Alaunos Therapeutics USD 2.38M 172K Mar/2026
Aurora Cannabis CAD 58.95M 2.24M Mar/2026
Canopy Growth CAD 422.07M 53.78M Mar/2026
Cronos Group USD 370.73M 5.53M Jun/2026
Dianthus Therapeutics USD 54.58M 11.36M Mar/2026
Divis Laboratories Ltd INR 265.47M 0 Mar/2026
Ionis Pharmaceuticals USD 165.64M 265K Jun/2026
IQVIA Holdings USD 164.6M 2.3M Jun/2026
Knight Therapeutics CAD 99.68M 24.66K Sep/2025
Moderna USD 391M 2M Sep/2025
Organigram Holdings CAD 136.47M 1.34M Mar/2026
Organon & Co USD 262.61M 40K Jun/2026
Revvity USD 111.63M 174K Jun/2026
Tectonic Therapeutic USD 18.83M 92.19K Mar/2026
Tilray USD 116.52M 5.01M Sep/2025
Viatris USD 1.16B 9.19M Jun/2026
Xeris Pharmaceuticals USD 172.56M 6.34M Mar/2026
Zealand Pharma A/S 70.66M 53K Mar/2026